Roles of the scaffolding proteins NHERF in liver biology

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 3, 2011, Pages 176-181

  Clapéron, Audrey ^a,b   Mergey, Martine ^a,b   Fouassier, Laura ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; NUCLEAR MATRIX PROTEIN; PHOSPHOPROTEIN; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR;

ANIMAL; EPITHELIUM; HUMAN; LIVER; PHYSIOLOGY; REVIEW;

ANIMALS; EPITHELIUM; HUMANS; LIVER; MEMBRANE PROTEINS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PHOSPHOPROTEINS; SODIUM-HYDROGEN ANTIPORTER;

MLCS; MLOWN;

EID: 80052307962     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2010.11.009     Document Type: Short Survey

References (56)

1. Vondriska, T.M., Pass, J.M., Ping, P., Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol 37 (2004), 391–397.
2. Dard, N., Peter, M., Scaffold proteins in MAP kinase signaling: more than simple passive activating platforms. Bioessays 28 (2006), 146–156.
3. Claperon, A., Therrien, M., KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 26 (2007), 3143–3158.
4. Cortese, M.S., Uversky, V.N., Dunker, A.K., Intrinsic disorder in scaffold proteins: getting more from less. Prog Biophys Mol Biol 98 (2008), 85–106.
5. Hung, A.Y., Sheng, M., PDZ domains: structural modules for protein complex assembly. J Biol Chem 277 (2002), 5699–5702.
6. Nourry, C., Grant, S.G., Borg, J.P., PDZ domain proteins: plug and play!. Sci STKE, 2003, 2003, RE7.
7. Fouassier, L., Yun, C.C., Fitz, J.G., Doctor, R.B., Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions. J Biol Chem 275 (2000), 25039–25045.
8. Lau, A.G., Hall, R.A., Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl-termini and by phosphorylation. Biochemistry 40 (2001), 8572–8580.
9. Gisler, S.M., Madjdpour, C., Bacic, D., Pribanic, S., Taylor, S.S., Biber, J., et al. PDZK1: II. an anchoring site for the PKA-binding protein D-AKAP2 in renal proximal tubular cells. Kidney Int 64 (2003), 1746–1754.
10. Weinman, E.J., Steplock, D., Wang, Y., Shenolikar, S., Characterization of a protein co-factor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger. J Clin Invest 95 (1995), 2143–2149.
11. Reczek, D., Berryman, M., Bretscher, A., Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139 (1997), 169–179.
12. Yun, C.H., Lamprecht, G., Forster, D.V., Sidor, A., NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin. J Biol Chem 273 (1998), 25856–25863.
13. Yun, C.H., Oh, S., Zizak, M., Steplock, D., Tsao, S., Tse, C.M., et al. cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci U S A 94 (1997), 3010–3015.
14. Custer, M., Spindler, B., Verrey, F., Murer, H., Biber, J., Identificationof a new gene product (diphor-1) regulated by dietary phosphate. Am J Physiol 273 (1997), F801–F806.
15. Kocher, O., Comella, N., Gilchrist, A., Pal, R., Tognazzi, K., Brown, L.F., et al. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab Invest 79 (1999), 1161–1170.
16. Wang, S., Yue, H., Derin, R.B., Guggino, W.B., Li, M., Accessory protein facilitated CFTR-CFTR interaction. a molecular mecanism to potentiate the chloride channel activity. Cell 103 (2000), 169–179.
17. Gisler, S.M., Stagljar, I., Traebert, M., Bacic, D., Biber, J., Murer, H., Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 276 (2001), 9206–9213.
18. Scott, R.O., Thelin, W.R., Milgram, S.L., A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor. J Biol Chem 277 (2002), 22934–22941.
19. Ediger, T.R., Kraus, W.L., Weinman, E.J., Katzenellenbogen, B.S., Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140 (1999), 2976–2982.
20. Ingraffea, J., Reczek, D., Bretscher, A., Distinct cell type-specific expression of scaffolding proteins EBP50 and E3KARP: EBP50 is generally expressed with ezrin in specific epithelia, whereas E3KARP is not. Eur J Cell Biol 81 (2002), 61–68.
21. Fouassier, L., Rosenberg, P., Mergey, M., Saubamea, B., Claperon, A., Kinnman, N., et al. Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 174 (2009), 869–880.
22. Fouassier, L., Duan, C.Y., Feranchak, A.P., Yun, C.H., Sutherland, E., Simon, F., et al. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 33 (2001), 166–176.
23. White, K.E., Biber, J., Murer, H., Econs, M.J., A PDZ domain-containing protein with homology to Diphor-1 maps human chromosome 1q21. Ann Hum Genet 62 (1998), 287–290.
24. Short, D.B., Trotter, K.W., Reczek, D., Kreda, S.M., Bretscher, A., Boucher, R.C., et al. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 273 (1998), 19797–19801.
25. Wang, S., Raab, R.W., Schatz, P.J., Guggino, W.B., Li, M., Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance. FEBS Lett 427 (1998), 103–108.
26. Sun, F., Hug, M.J., Lewarchik, C.M., Yun, C.H., Bradbury, N.A., Frizzell, R.A., E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J Biol Chem 275 (2000), 29539–29546.
27. Fitz, J.G., Basavappa, S., MacGill, J., Melhus, O., Cohn, J.A., Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91 (1993), 319–328.
28. Lamprecht, G., Seidler, U., The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am J Physiol Gastrointest Liver Physiol 291 (2006), G766–G777.
29. Hegedus, T., Sessler, T., Scott, R., Thelin, W., Bakos, E., Varadi, A., et al. C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem Biophys Res Commun 302 (2003), 454–461.
30. Li, M., Wang, W., Soroka, C.J., Mennone, A., Harry, K., Weiman, E.J., et al. NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J Biol Chem 285 (2010), 19299–19307.
31. Hoque, M.T., Cole, S.P., Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4. Cancer Res 68 (2008), 4802–4809.
32. Shenolikar, S., Voltz, J.W., Minkoff, C.M., Wade, J.B., Weinman, E.J., Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci U S A 99 (2002), 11470–11475.
33. Morales, F.C., Takahashi, Y., Kreimann, E.L., Georgescu, M.M., Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc Natl Acad Sci U S A 101 (2004), 17705–17710.
34. Emi, Y., Nomura, S., Yokota, H., Sakaguchi, M., ATP-binding cassette transporter isoform C2 (ABCC2) localizes to the apical plasma membrane via interactions with PDZK1 scaffolding protein. J Biochem, 2010 [E-pub ahead of print].
35. Hoque, M.T., Conseil, G., Cole, S.P., Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells. Biochem Biophys Res Commun 379 (2009), 60–64.
36. Rius, M., Nies, A.T., Hummel-Eisenbeiss, J., Jedlitschky, G., Keppler, D., Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38 (2003), 374–384.
37. Wang, P., Wang, J.J., Xiao, Y., Murray, J.W., Novikoff, P.M., Angeletti, R.H., et al. Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface. J Biol Chem 280 (2005), 30143–30149.
38. Ikemoto, M., Arai, H., Feng, D., Tanaka, K., Aoki, J., Dohmae, N., et al. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A 97 (2000), 6538–6543.
39. Kocher, O., Yesilaltay, A., Cirovic, C., Pal, R., Rigotti, A., Krieger, M., Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 278 (2003), 52820–52825.
40. Fenske, S.A., Yesilaltay, A., Pal, R., Daniels, K., Rigotti, A., Krieger, M., et al. Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization. J Biol Chem 283 (2008), 22097–22104.
41. Fenske, S.A., Yesilaltay, A., Pal, R., Daniels, K., Barker, C., Quinones, V., et al. Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ dmains of PDZK1. J Biol Chem 284 (2009), 5797–5806.
42. Ediger, T.R., Park, S.E., Katzenellenbogen, B.S., Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Mol Endocrinol 16 (2002), 1828–1839.
43. Alvaro, D., Alpini, G., Onori, P., Perego, L., Svegliata Baroni, G., Franchitto, A., et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119 (2000), 1681–1691.
44. Ghosh, M.G., Thompson, D.A., Weigel, R.J., PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60 (2000), 6367–6375.
45. Walker, G., MacLeod, K., Williams, A.R., Cameron, D.A., Smyth, J.F., Langdon, S.P., Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol 106 (2007), 461–468.
46. Georgescu, M.M., Morales, F.C., Molina, J.R., Hayashi, Y., Roles of NHERF1/EBP50 in cancer. Curr Mol Med 8 (2008), 459–468.
47. Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., Hirohashi, S., EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma, Hepatology 38 (2003), 178–186.
48. Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457 (2008), 200–204.
49. Clapéron A, et al. J Hepatol 2010;52:S18.
50. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989–5005.
51. Curto, M., Cole, B.K., Lallemand, D., Liu, C.H., McClatchey, A.I., Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177 (2007), 893–903.
52. Helms, C., Cao, L., Krueger, J.G., Wijsman, E.M., Chamian, F., Gordon, D., et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35 (2003), 349–356.
53. Karim, Z., Gerard, B., Bakouh, N., Alili, R., Leroy, C., Beck, L., et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359 (2008), 1128–1135.
54. Sullivan, S., Alex, P., Dassopoulos, T., Zachos, N.C., Iacobuzio-Donahue, C., Donowitz, M., et al. Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis 15 (2009), 261–274.
55. Dev, K.K., Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 3 (2004), 1047–1056.
56. Wang, N.X., Lee, H.J., Zheng, J.J., Therapeutic use of PDZ protein-protein interaction antagonism. Drug News Perspect 21 (2008), 137–141.